SGMO

NASDAQ · Biotechnology

Sangamo Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.40

+0.05 (+13.15%)

As of Feb 8, 2:08 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 8 73%

Hold 3 27%

Sell 0 0%

Price Target

Analyst Price Target +4,972.5% upside

Low Target $11.90

Average Target $20.29

High Target $29.33

Current Price $0.40

Current
$0.40

Target
$20.29

$11.90 $20.29 avg $29.33

Scenario Analysis

Bear Case

$11.90

2,875.0%

Low target

Base Case

$20.29

+4,972.5%

Avg target

Bull Case

$29.33

+7,232.5%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$22.17

-98.2% from high

52-Week Low

$9.45

+-95.8% from low

Target vs 52W High

$20.29

-8.5% vs high

Next Earnings Report

Feb 25, 2026 · After Market Close

until earnings

EPS Est: $-0.06

Earnings in 8 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%